The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
AimGlucagon‐like peptide‐1 (GLP‐1) has been increasingly recognized for treating diabetes mellitus, and for its potential to effectively treat non‐alcoholic fatty liver disease (NAFLD). However, the mechanisms of GLP‐1 induction in NAFLD are not completely known. We investigated whether GLP‐1 can protect against NAFLD by alleviating endoplasmic reticulum (ER) stress.
MethodsMale Sprague–Dawley rats...
The aim of this study was to assess the efficiency and safety of combination therapy of ursodeoxycholic acid (UDCA) and bezafibrate for primary biliary cirrhosis. A meta‐analysis of all long‐term randomized controlled trials comparing the combination of UDCA and bezafibrate with UDCA monotherapy was performed via electronic searches. Seven trials, which included 177 patients, were assessed. Combination...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.